Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35,396 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PD-1/PD-L1 Inhibitor Plus Chemotherapy Versus PD-1/PD-L1 Inhibitor in Microsatellite Instability Gastrointestinal Cancers: A Multicenter Retrospective Study.
Chen M, Wang Z, Liu Z, Deng T, Wang X, Chang Z, Zhang Q, Yang W, Liu N, Ji Z, Zhang X, Wang X, Peng Z, Li Y, Cao Y, Jin X, Lu H, Qu H, Tang Y, Xu C, Fang W, Zhang H, Yan D, Wang L, Li J, Zhang J, Wang Q, Xue L, Yin F, Han G, Cheng Z, Liu Q, Jin Y, Zhang Y, Li L, Cao B, Yao Y, Chen Z, Zou J, Ying J, Wei Q, Tian T, Zhao W, Li L, Zhang T, Song F, Ba YE, Li N, Gao H, Ji Y, Bao L, Zhao X, Cai J, Yuan Z, Shen L, Li J. Chen M, et al. Among authors: zhang q, zhang t, zhang j, zhang x, zhang h, zhang y. JCO Precis Oncol. 2023 Mar;7:e2200463. doi: 10.1200/PO.22.00463. JCO Precis Oncol. 2023. PMID: 36996375 Free PMC article.
The binding of an anti-PD-1 antibody to FcγRΙ has a profound impact on its biological functions.
Zhang T, Song X, Xu L, Ma J, Zhang Y, Gong W, Zhang Y, Zhou X, Wang Z, Wang Y, Shi Y, Bai H, Liu N, Yang X, Cui X, Cao Y, Liu Q, Song J, Li Y, Tang Z, Guo M, Wang L, Li K. Zhang T, et al. Among authors: zhang y. Cancer Immunol Immunother. 2018 Jul;67(7):1079-1090. doi: 10.1007/s00262-018-2160-x. Epub 2018 Apr 23. Cancer Immunol Immunother. 2018. PMID: 29687231 Free PMC article.
An Fc-Competent Anti-Human TIGIT Blocking Antibody Ociperlimab (BGB-A1217) Elicits Strong Immune Responses and Potent Anti-Tumor Efficacy in Pre-Clinical Models.
Chen X, Xue L, Ding X, Zhang J, Jiang L, Liu S, Hou H, Jiang B, Cheng L, Zhu Q, Zhang L, Zhou X, Ma J, Liu Q, Li Y, Ren Z, Jiang B, Song X, Song J, Jin W, Wei M, Shen Z, Liu X, Wang L, Li K, Zhang T. Chen X, et al. Among authors: zhang l, zhang t, zhang j. Front Immunol. 2022 Feb 22;13:828319. doi: 10.3389/fimmu.2022.828319. eCollection 2022. Front Immunol. 2022. PMID: 35273608 Free PMC article.
Emerging contaminants: A One Health perspective.
Wang F, Xiang L, Sze-Yin Leung K, Elsner M, Zhang Y, Guo Y, Pan B, Sun H, An T, Ying G, Brooks BW, Hou D, Helbling DE, Sun J, Qiu H, Vogel TM, Zhang W, Gao Y, Simpson MJ, Luo Y, Chang SX, Su G, Wong BM, Fu TM, Zhu D, Jobst KJ, Ge C, Coulon F, Harindintwali JD, Zeng X, Wang H, Fu Y, Wei Z, Lohmann R, Chen C, Song Y, Sanchez-Cid C, Wang Y, El-Naggar A, Yao Y, Huang Y, Cheuk-Fung Law J, Gu C, Shen H, Gao Y, Qin C, Li H, Zhang T, Corcoll N, Liu M, Alessi DS, Li H, Brandt KK, Pico Y, Gu C, Guo J, Su J, Corvini P, Ye M, Rocha-Santos T, He H, Yang Y, Tong M, Zhang W, Suanon F, Brahushi F, Wang Z, Hashsham SA, Virta M, Yuan Q, Jiang G, Tremblay LA, Bu Q, Wu J, Peijnenburg W, Topp E, Cao X, Jiang X, Zheng M, Zhang T, Luo Y, Zhu L, Li X, Barceló D, Chen J, Xing B, Amelung W, Cai Z, Naidu R, Shen Q, Pawliszyn J, Zhu YG, Schaeffer A, Rillig MC, Wu F, Yu G, Tiedje JM. Wang F, et al. Among authors: zhang t. Innovation (Camb). 2024 Mar 13;5(4):100612. doi: 10.1016/j.xinn.2024.100612. eCollection 2024 Jul 1. Innovation (Camb). 2024. PMID: 38756954 Free PMC article. Review.
35,396 results
You have reached the last available page of results. Please see the User Guide for more information.